Impact of mobile health technologies on HPV vaccination uptake among mothers of unvaccinated girls aged 9–14 years in Lagos: A randomized controlled trial (mHealth-HPVac)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202406727470443

Enrollment

224

Registered

2024-06-06

Start date

2024-05-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

mobile health technology via short text messages

Usual condition

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Mothers of unvaccinated girls aged 9–14 years Those who express willingness to vaccinate their children Those who own and use a personal cellphone Those who are free from any mental or physical disabilities that inhibit them from understanding the implications of the study Those not considering relocating from their current residence within the next year

Exclusion criteria

Exclusion criteria: Refusal of consent or withdrawal of consent during the study.

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the rate of uptake of single-dose HPV vaccination after 6 months of enrolment.	—

Secondary

Measure	Time frame
The secondary endpoints are predictors of HPV vaccination uptake among young or adolescent girls of participating mothers after 6 months of enrolment.	—

Countries

Nigeria

Contacts

Public ContactKehinde oKUNADE

Associate Professor of Obstetrics and Gynaecology College of Medicine University of Lagos

SOKUNADE@UNILAG.EDU.NG+2348034728139

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026